Share Email Print

Proceedings Paper

Flow cytometric assay for analysis of cytotoxic effects of potential drugs on human peripheral blood leukocytes
Author(s): Kathleen Nieschke; Anja Mittag; Karolina Golab; Jozsef Bocsi; Arkadiusz Pierzchalski; Wojciech Kamysz; Attila Tarnok
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Toxicity test of new chemicals belongs to the first steps in the drug screening, using different cultured cell lines. However, primary human cells represent the human organism better than cultured tumor derived cell lines. We developed a very gentle toxicity assay for isolation and incubation of human peripheral blood leukocytes (PBL) and tested it using different bioactive oligopeptides (OP). Effects of different PBL isolation methods (red blood cell lysis; Histopaque isolation among others), different incubation tubes (e.g. FACS tubes), anticoagulants and blood sources on PBL viability were tested using propidium iodide-exclusion as viability measure (incubation time: 60 min, 36°C) and flow cytometry. Toxicity concentration and time-depended effects (10-60 min, 36 °C, 0-100 μg /ml of OP) on human PBL were analyzed. Erythrocyte lysis by hypotonic shock (dH2O) was the fastest PBL isolation method with highest viability (>85%) compared to NH4Cl-Lysis (49%). Density gradient centrifugation led to neutrophil granulocyte cell loss. Heparin anticoagulation resulted in higher viability than EDTA. Conical 1.5 mL and 2 mL micro-reaction tubes (both polypropylene (PP)) had the highest viability (99% and 97%) compared to other tubes, i.e. three types of 5.0 mL round-bottom tubes PP (opaque-60%), PP (blue-62%), Polystyrene (PS-64%). Viability of PBL did not differ between venous and capillary blood. A gentle reproducible preparation and analytical toxicity-assay for human PBL was developed and evaluated. Using our assay toxicity, time-course, dose-dependence and aggregate formation by OP could be clearly differentiated and quantified. This novel assay enables for rapid and cost effective multiparametric toxicological screening and pharmacological testing on primary human PBL and can be adapted to high-throughput-screening.°z

Paper Details

Date Published: 4 March 2014
PDF: 12 pages
Proc. SPIE 8947, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XII, 89470W (4 March 2014); doi: 10.1117/12.2037741
Show Author Affiliations
Kathleen Nieschke, Univ. of Leipzig (Germany)
Anja Mittag, Univ. of Leipzig (Germany)
Karolina Golab, Univ. of Chicago (United States)
Jozsef Bocsi, Univ. of Leipzig (Germany)
Arkadiusz Pierzchalski, Univ. of Leipzig (Germany)
Wojciech Kamysz, Medical Univ. of Gdansk (Poland)
Attila Tarnok, Univ. of Leipzig (Germany)

Published in SPIE Proceedings Vol. 8947:
Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XII
Daniel L. Farkas; Dan V. Nicolau; Robert C. Leif, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?